美国 · 平台与数据 · The Motley Fool

Where Will Jazz Pharmaceuticals Be in 5 Years? Oncology Is Becoming Its Growth Engine

来源：The Motley Fool · 美国 1 小时前

Jazz Pharmaceuticals' strategy is starting to pay dividends.

在 The Motley Fool 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.fool.com)

推荐阅读

Greenbrier Companies, Inc. (The) (NYSE:GBX) Stock Has Average Price Target of $42.67

Is that used EV worth the price? This checklist could save you thousands of dollars.

Robinhood CEO’s AI startup Harmonic expands into software, chip design verification

Myro (MYRO) Price Prediction: 2025, 2026, 2030

Galaxy Digital Stock Surges After Quarterly Earnings Crush Estimates

Novartis Raises Guidance After Trial Setbacks Hit Profit